Who has invested in Fathom Therapeutics?

Sutter Hill Ventures, Chemistry, Alexandria Venture Investments, NY Ventures are named among the investors backing Fathom Therapeutics.

Fathom Therapeutics Funding: $47M Raised, Series A (2026)

Fathom Therapeutics funding overview

Fathom Therapeutics is a Biotech company based in New York. Fathom Therapeutics has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2026. The round record for Fathom Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Sutter Hill Ventures, Chemistry, Alexandria Venture Investments, NY Ventures. 4 distinct backers are named across the disclosed rounds.

Fathom Therapeutics at a glance

Total raised: $47M
Latest round: Series A
Latest round date: April 2026
Industry: Biotech
Headquarters: New York
Notable investors: Sutter Hill Ventures, Chemistry, Alexandria Venture Investments, NY Ventures

Frequently asked about Fathom Therapeutics funding

How much has Fathom Therapeutics raised?: Fathom Therapeutics has raised $47M in total disclosed funding across the rounds on record.
Who has invested in Fathom Therapeutics?: Sutter Hill Ventures, Chemistry, Alexandria Venture Investments, NY Ventures are named among the investors backing Fathom Therapeutics.
What was the latest Fathom Therapeutics funding round?: The most recent disclosed round is a Series A, announced in April 2026.
Where is Fathom Therapeutics based?: Fathom Therapeutics is based in New York.
What sector does Fathom Therapeutics operate in?: Fathom Therapeutics is tracked under Biotech from New York, with $47M in disclosed funding.
When did Fathom Therapeutics last raise?: The last disclosed Fathom Therapeutics round closed in April 2026 at Series A.

Totals shown for Fathom Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in New York and the investors behind them below.

Fathom Therapeutics Funding: $47M Raised, Series A (2026)

Fathom Therapeutics funding overview

Fathom Therapeutics at a glance

Frequently asked about Fathom Therapeutics funding

Fathom Therapeutics founders (1)

Companies related to Fathom Therapeutics (40)

Browse related funding lists (7)